Youth Power Action Feasibility Study of Online Support Group Intervention Among Adolescents Living With HIV in Nigeria

Overview

This study will examine the feasibility and acceptability of an intervention designed to improve retention in HIV care services and improve anti-retroviral therapy (ART) adherence among adolescents ages 15-19 years living with HIV enrolled in ART services.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 15, 2018

Detailed Description

Study aim is to examine the feasibility and acceptability of an intervention designed to improve retention in HIV care services and improve anti-retroviral therapy (ART) adherence among adolescents ages 15-19 years living with HIV enrolled in ART services. A single group, pre/posttest design including structured questionnaires with adolescents living with HIV. Additionally, we will abstract clinical data from the medical record system. We will also conduct in-depth interviews with a subset of participants, as well as health care staff who are engaged in the intervention, at endline. The objectives of this study are: 1. To examine the feasibility of implementing a mobile/electronic health (m/eHealth) intervention designed to improve retention in HIV care services and ART adherence among ALHIV ages 15-19 years through an online support group (using Facebook). 2. To assess acceptability of and engagement in the intervention by the target audience to inform improvements to the intervention. 3. To gather preliminary data on the psycho-social and health-related outcomes that the intervention is designed to affect to inform an outcome evaluation study that will be conducted following the conclusion of the feasibility study. 4. To collect information on recruitment, informed consent and data collection processes to inform the outcome evaluation study of the current intervention that will be conducted once findings from this feasibility study are incorporated into the intervention design.

Interventions

  • Behavioral: Online support group
    • Participants will be enrolled to form five groups of 8 to 10 participants, and then participants will participate in the 6 sessions of the structured educational and group counseling curriculum through the online platform. The m/eHealth intervention components include: Informational messages that reflect the content of the structured group counseling curriculum, Positive Connections, and are posted to the group wall on a regular basis Moderated, closed group chats where ALHIV can interact with their peers and with a trained health counselor on a biweekly basis Access to a trained counselor via Facebook Messenger (during normal business hours) for the duration of the intervention who will be able to provide information or basic counseling on ART/HIV care related issues, with referral to health care services as needed

Arms, Groups and Cohorts

  • Experimental: Online support group
    • Participants will be enrolled to receive six sessions from the Positive Connections curriculum through the m/eHealth intervention that will use Facebook to conduct online structured support groups.

Clinical Trial Outcome Measures

Primary Measures

  • Percentage of Active Members Who Have at Least One Post in Group Chat Session.
    • Time Frame: 3 months
    • Participants level of engagement in support group activities informs on the feasibility of intervention, measured by percentage of active members who have at least one post in group chat session.

Secondary Measures

  • Acceptability Score
    • Time Frame: 3 months
    • Acceptability score: A set of ten items asking if participants agreed=1 or disagreed=0 with statements on acceptability. Score represents a sum of the 10 items with a range of 0 to 10, and a greater number indicating agreement with more acceptability items.
  • Adherence to ART as Measured by the AACTG Adherence Assessment
    • Time Frame: 3 months
    • Proportion of participants who report not having missed any ART doses in past 3 days.
  • Adherence to Follow-up Visit Within 1 Month of Scheduled Date
    • Time Frame: 3 months
    • Retention in HIV services will be measured using data abstracted from the medical record system on date of visits between enrollment and the endline of this study. To be considered retained in HIV services, an individual must, at 3 months after enrollment, have attended his/her most recently scheduled clinical follow-up visit within 1 month of the date when it was scheduled to take place.

Participating in This Clinical Trial

Inclusion Criteria

  • HIV positive and currently on ART for at least 6 months – Age 15 to 19 years – Can demonstrate basic literacy necessary to participate in online chats Exclusion Criteria:

  • Not planning to remain in the study area (within Akwa Ibom State) for the duration of the study (approximately 6 months) – Currently enrolled in an in-person support group – Currently enrolled in another research study related to HIV service retention or ART adherence – Critically or severely ill requiring hospitalization or such that the individual is unable to provide informed consent at the time of study recruitment

Gender Eligibility: All

Minimum Age: 15 Years

Maximum Age: 19 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • FHI 360
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Lisa S Dulli, PhD, Principal Investigator, FHI 360

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.